According to one study, the average length of time from the start of clinical testing to marketing is 90.3 months (7.5 years). Longer timelines increase costs and decrease revenues. Longer studies are needed to see if any safety issues arise when drugs are taken long-term to manage chronic diseases. The “one-off” nature of trial organ
Studies estimate that it now costs somewhere between $161 million and $2 billion to bring a new drug to market.
EXECUTIVE SUMMARY Contents Introduction and Background Data Needs and Priorities Research and Development to Improve HHS Data Collection Systems Web Panels and Web Surveys Timeliness of HHS Data Systems Access to HHS Data Non-Traditional Data Sources
Understanding Disparities in Persons with Multiple Chronic Conditions: Research Approaches and Datasets. Appendix E – Review of National Datasets and Data Systems: Summary Tables
Disclaimer: The information contained in this appendix was compiled by Abt Associates Inc. under contract #HHSP2333700IT to the Assistant Secretary for Planning and Evaluation (ASPE) in September 2013. Abt and ASPE are not liable for the accuracy or completeness of the information contained in this document, as the specifications of each data sy
Research Addressing the HHS Strategic Framework on Multiple Chronic Conditions. Appendix 2: Technical Advisory Group Members
The Technical Advisory Group (TAG) included experts from federal agencies who were consulted about the content of the studies. The Appendix lists the members and their affiliations. TAG members participated in an initial in-person meeting in December 2012 and provided feedback on the original literature review to determine additional databases, gr
Research Addressing the HHS Strategic Framework on Multiple Chronic Conditions. Appendix 1: Literature Search Strategy
The literature search strategy outlines the MEDLINE search terms that were used to conduct the literature review of peer-reviewed and grey literature for both White Paper 1, “Understanding the High Prevalence of Low-Prevalence Chronic Disease Combinations: Databases and Methods for Research,” and White Paper 2, “Understanding Disparities in
Most MCC research in the United States has primarily been conducted on chronic conditions that are highly prevalent and well-known. Low-prevalence conditions and less prevalent combinations of conditions have not been well studied, even though patients with these findings represent one-third of all Medicare beneficiaries and 79% of expenditures.
Research Addressing the HHS Strategic Framework on Multiple Chronic Conditions. White paper #1: Understanding the High Prevalence of Low-Prevalence Chronic Disease Combinations: Databases and Methods for Research
The purpose of the first white paper was to explore how the “long tail” of the MCC population can be appropriately studied. As a first step, ASPE wanted to identify the existing data sources that could be used to understand the population, and to consider what steps might be taken in the future to improve the knowledgebase. ASPE’s guiding st
Understanding Disparities in Persons with Multiple Chronic Conditions: Research Approaches and Datasets. Appendix B – Literature Search Methodology
Search Strategy MEDLINE Date - Last 10 Years (as of January 1, 2013) Language - English Limits - Human Limits - Abstract Available Search Field Tags - All fields Key terms
Understanding Disparities in Persons with Multiple Chronic Conditions: Research Approaches and Datasets. Appendices
The appendices listed below are attached. Appendix A – HHS Standards for Race, Ethnicity, Sex, Primary Language, and Disability Status (2011) The HHS Standards for Race, Ethnicity, Sex, Primary Language, and Disability Status are the current standards for collecting disparities data in federal surveys. These standards were developed in res
Understanding Disparities in Persons with Multiple Chronic Conditions: Research Approaches and Datasets. 9. References
Agency for Healthcare Research and Quality. (2008). Creation of new race-ethnicity codes and socioeconomic status (SES) indicators for Medicare beneficiaries. (AHRQ Publication No. 08-0029-EF). Rockville, MD.
Understanding Disparities in Persons with Multiple Chronic Conditions: Research Approaches and Datasets. 4.3 Disease Specific Disparities in the MCC Population
For the purposes of the paper, disease-specific disparities are defined as disparities affecting individuals with a specific combination of chronic conditions. For example, using CMS administrative data Shaya and colleagues (2009) found that African American patients with both COPD and asthma had fewer outpatient visits, hospitalizations and used
Due to resource constraints, a small number of surveys that met these general requirements were not reviewed. In the discussion of the surveys presented in Chapter II , we note instances of surveys that meet the above criteria and/or were identified as being used by federal staff but were not included in our review.
Assessing the Need for a National Disability Survey: Final Report. C. Facilitate Increased Use of Administrative Data
As discussed in Chapter II , administrative data sources are extensively used by federal and state agencies and, when linked with survey data, add a longitudinal perspective to cross-sectional data. Administrative data also provide more accurate and detailed information about program participation and service use than can be collected via survey.
This is the final report of a project that assesses the need for developing and fielding another national disability survey data collection effort. It presents the findings from three principal project activities designed to assess whether existing data are sufficient to answer key disability-related research questions identified by the staffs of
Medicaid Financing for Services in Supportive Housing for Chronically Homeless People: Current Practices and Opportunities. 3.4. Looking Ahead to 2014: How is Coverage for Mental Health Services Likely to Change?
States may use Benchmark Plans to make Medicaid services available to some or all people who become Medicaid beneficiaries in 2014, including homeless people and PSH tenants.
Medicaid Financing for Services in Supportive Housing for Chronically Homeless People: Current Practices and Opportunities. 3.2. Howare Mental Health Services Provided to Permanent Supportive Housing Residents?
All three of the states we visited use the MRO to provide Medicaid reimbursement for a range of services delivered in community settings, including PSH. 18 3.2.1. Massachusetts
Medicaid Financing for Services in Supportive Housing for Chronically Homeless People: Current Practices and Opportunities
This Issue Paper describes the ways that Medicaid is being used now and might be used in the future under provisions of the Affordable Care Act of 2010 to serve chronically homeless people. [67 PDF pages]
Design of a Demonstration of Coordinated Housing, Health and Long-Term Care Services and Supports for Low-Income Older Adults. C. Target Population
The demonstration will target low and modest-income older adults who qualify for federal housing subsidies, including senior residents of Section 202 properties, public housing, seniors who obtain housing through Section 8 vouchers and older adults living in Low-Income Housing Tax Credit (LIHTC) properties. Seniors with similar income characterist
Design of a Demonstration of Coordinated Housing, Health and Long-Term Care Services and Supports for Low-Income Older Adults
This conceptual framework examines the possible ways that housing sites can link health and long-term services and supports, and potential ways that HUD and HHS could design a demonstration of such a model. [31 PDF pages]